| AQS Stock | | | CAD 0.01 0.00 0.00% |
Aequus Pharmaceuticals financial indicator trend analysis is way more than just evaluating Aequus Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aequus Pharmaceuticals is a good investment. Please check the relationship between Aequus Pharmaceuticals Cash and its Total Assets accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Aequus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Cash vs Total Assets
Cash vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Aequus Pharmaceuticals Cash account and
Total Assets. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Aequus Pharmaceuticals' Cash and Total Assets is 0.84. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Total Assets in the same time period over historical financial statements of Aequus Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Aequus Pharmaceuticals' Cash and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Aequus Pharmaceuticals are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Cash i.e., Aequus Pharmaceuticals' Cash and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.84 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Cash
Cash refers to the most liquid asset of Aequus Pharmaceuticals, which is listed under current asset account on Aequus Pharmaceuticals balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Aequus Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Aequus Pharmaceuticals account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Total Assets
Total assets refers to the total amount of Aequus Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Aequus Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Aequus Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aequus Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Aequus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
At this time, Aequus Pharmaceuticals'
Selling General Administrative is fairly stable compared to the past year.
Sales General And Administrative To Revenue is likely to climb to 8.81 in 2024, whereas
Enterprise Value Over EBITDA is likely to drop
(3.21) in 2024.
Aequus Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Aequus Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aequus Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Aequus Stock Analysis
When running Aequus Pharmaceuticals' price analysis, check to
measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.